CLGNNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
CollPlant Biotechnologies Ltd
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 26, 2026
$3.56−0.06 (-1.79%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
CollPlant Biotechnologies statistics
Financials through Dec 31, 2025, price as of Oct 19, 2026, median of Orthopedic, Prosthetic & Surgical Appliances & Supplies companies for comparison
Valuation
| Measure | CollPlant Biotechnologies | Industry median |
|---|---|---|
| Market Cap | $45.58M | $230.55M |
| Enterprise Value | $39.99M | $202.97M |
| PS Ratio | 19.22 | 3.11 |
| PB Ratio | 7.50 | 3.14 |
| P/TBV Ratio | 7.59 | 4.57 |
Enterprise value
| Measure | CollPlant Biotechnologies | Industry median |
|---|---|---|
| EV / Sales | 16.87 | 2.92 |
Income (trailing twelve months)
| Measure | CollPlant Biotechnologies | Industry median |
|---|---|---|
| Revenue | $2.37M | $102.39M |
| Gross Profit | $1.54M | $60.36M |
| Operating Income | -$11.48M | -$4.31M |
| Net Income | -$11.49M | -$6.57M |
| EBITDA | -$10.57M | -$1.98M |
| EPS (Diluted) | -$0.94 | -$0.07 |
Margins
| Measure | CollPlant Biotechnologies | Industry median |
|---|---|---|
| Gross Margin | 64.8% | 55.1% |
| Operating Margin | -484.3% | -6.04% |
| Profit Margin | -484.6% | -10.5% |
| EBITDA Margin | -445.8% | -2.67% |
| FCF Margin | -398.4% | -0.30% |
Returns
| Measure | CollPlant Biotechnologies | Industry median |
|---|---|---|
| Return on Equity (ROE) | -117.6% | -19.2% |
| Return on Assets (ROA) | -77.9% | -13.3% |
| Return on Invested Capital (ROIC) | -886.8% | -4.11% |
| Return on Capital Employed (ROCE) | -141.5% | -9.07% |
Growth
| Measure | CollPlant Biotechnologies | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 360.4% | 8.85% |
| Revenue Growth (3Y CAGR) | 99.4% | 7.08% |
| Revenue Growth (5Y CAGR) | -17.3% | 11.8% |
Balance sheet
| Measure | CollPlant Biotechnologies | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $5.59M | $37.33M |
| Net Cash (Debt) | $5.59M | $3.92M |
| Net Cash Per Share | $0.44 | $0.28 |
| Equity (Book Value) | $6.08M | $57.36M |
| Book Value Per Share | $0.47 | $2.81 |
| Tangible Book Value | $6.01M | $10.71M |
| Working Capital | $4.08M | $54.64M |
Financial position
| Measure | CollPlant Biotechnologies | Industry median |
|---|---|---|
| Current Ratio | 2.53 | 2.50 |
| Quick Ratio | 2.09 | 1.54 |
Cash flow (trailing twelve months)
| Measure | CollPlant Biotechnologies | Industry median |
|---|---|---|
| Operating Cash Flow | -$9.42M | -$653.46K |
| Capital Expenditures | -$28.00K | -$3.69M |
| Free Cash Flow | -$9.45M | -$835.02K |
| FCF Per Share | -$0.74 | -$0.02 |
Efficiency
| Measure | CollPlant Biotechnologies | Industry median |
|---|---|---|
| Asset Turnover | 0.16 | 0.59 |
| Inventory Turnover | 1.65 | 2.21 |
| Revenue Per Employee | $60.79K | $322.57K |
| Profits Per Employee | -$294.59K | -$51.88K |
| Employee Count | 39 | 185 |
Dividends and yields
| Measure | CollPlant Biotechnologies | Industry median |
|---|---|---|
| Earnings Yield | -25.2% | -6.91% |
| FCF Yield | -20.7% | -0.56% |
Shares
| Measure | CollPlant Biotechnologies | Industry median |
|---|---|---|
| Shares Outstanding | 12,803,000 | 44,856,700 |
| Shares Change (YoY) | 6.54% | 3.35% |
| Float | 7,756,170 | 37,097,900 |
| Shares Held by Insiders | 39.4% | 10.6% |
Scores
| Measure | CollPlant Biotechnologies | Industry median |
|---|---|---|
| Altman Z-Score | -13.23 | 1.95 |
| Piotroski F-Score | 3 | 5 |
Calculated by StockData from CollPlant Biotechnologies's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.